vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and EPR PROPERTIES (EPR). Click either name above to swap in a different company.

EPR PROPERTIES is the larger business by last-quarter revenue ($182.9M vs $121.8M, roughly 1.5× Core Laboratories Inc.). EPR PROPERTIES runs the higher net margin — 36.6% vs 4.2%, a 32.4% gap on every dollar of revenue. On growth, EPR PROPERTIES posted the faster year-over-year revenue change (3.2% vs -1.4%). EPR PROPERTIES produced more free cash flow last quarter ($269.2M vs $517.0K). Over the past eight quarters, EPR PROPERTIES's revenue compounded faster (4.6% CAGR vs -3.4%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

EPR Properties, formerly Entertainment Properties Trust, is a real estate investment trust based in Kansas City, Missouri, that invests in amusement parks, movie theaters, ski resorts, and other entertainment properties. It owns 353 properties as of 2022.

CLB vs EPR — Head-to-Head

Bigger by revenue
EPR
EPR
1.5× larger
EPR
$182.9M
$121.8M
CLB
Growing faster (revenue YoY)
EPR
EPR
+4.7% gap
EPR
3.2%
-1.4%
CLB
Higher net margin
EPR
EPR
32.4% more per $
EPR
36.6%
4.2%
CLB
More free cash flow
EPR
EPR
$268.7M more FCF
EPR
$269.2M
$517.0K
CLB
Faster 2-yr revenue CAGR
EPR
EPR
Annualised
EPR
4.6%
-3.4%
CLB

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLB
CLB
EPR
EPR
Revenue
$121.8M
$182.9M
Net Profit
$5.1M
$66.9M
Gross Margin
Operating Margin
1.5%
56.8%
Net Margin
4.2%
36.6%
Revenue YoY
-1.4%
3.2%
Net Profit YoY
897.0%
EPS (diluted)
$0.11
$0.80

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
EPR
EPR
Q1 26
$121.8M
Q4 25
$138.3M
$182.9M
Q3 25
$134.5M
$182.3M
Q2 25
$130.2M
$178.1M
Q1 25
$123.6M
$175.0M
Q4 24
$129.2M
$177.2M
Q3 24
$134.4M
$180.5M
Q2 24
$130.6M
$173.1M
Net Profit
CLB
CLB
EPR
EPR
Q1 26
$5.1M
Q4 25
$4.9M
$66.9M
Q3 25
$14.2M
$66.6M
Q2 25
$10.6M
$75.6M
Q1 25
$-154.0K
$65.8M
Q4 24
$7.4M
$-8.4M
Q3 24
$11.7M
$46.6M
Q2 24
$9.0M
$45.1M
Gross Margin
CLB
CLB
EPR
EPR
Q1 26
Q4 25
20.8%
Q3 25
22.0%
Q2 25
20.3%
Q1 25
19.5%
Q4 24
17.8%
Q3 24
20.5%
Q2 24
21.2%
Operating Margin
CLB
CLB
EPR
EPR
Q1 26
1.5%
Q4 25
11.5%
56.8%
Q3 25
15.6%
53.5%
Q2 25
11.7%
62.5%
Q1 25
3.6%
58.1%
Q4 24
11.0%
25.5%
Q3 24
14.7%
51.4%
Q2 24
12.3%
45.9%
Net Margin
CLB
CLB
EPR
EPR
Q1 26
4.2%
Q4 25
3.6%
36.6%
Q3 25
10.6%
36.5%
Q2 25
8.2%
42.5%
Q1 25
-0.1%
37.6%
Q4 24
5.7%
-4.7%
Q3 24
8.7%
25.8%
Q2 24
6.9%
26.1%
EPS (diluted)
CLB
CLB
EPR
EPR
Q1 26
$0.11
Q4 25
$0.11
$0.80
Q3 25
$0.30
$0.79
Q2 25
$0.22
$0.91
Q1 25
$0.00
$0.78
Q4 24
$0.15
$-0.19
Q3 24
$0.25
$0.53
Q2 24
$0.19
$0.51

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
EPR
EPR
Cash + ST InvestmentsLiquidity on hand
$22.8M
$90.6M
Total DebtLower is stronger
$2.9B
Stockholders' EquityBook value
$275.1M
$2.3B
Total Assets
$587.7M
$5.7B
Debt / EquityLower = less leverage
1.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
EPR
EPR
Q1 26
$22.8M
Q4 25
$22.7M
$90.6M
Q3 25
$25.6M
$13.7M
Q2 25
$31.2M
$13.0M
Q1 25
$22.1M
$20.6M
Q4 24
$19.2M
$22.1M
Q3 24
$21.5M
$35.3M
Q2 24
$17.7M
$33.7M
Total Debt
CLB
CLB
EPR
EPR
Q1 26
Q4 25
$110.3M
$2.9B
Q3 25
$114.1M
$2.8B
Q2 25
$124.6M
$2.8B
Q1 25
$124.4M
$2.8B
Q4 24
$126.1M
$2.9B
Q3 24
$139.9M
$2.9B
Q2 24
$147.6M
$2.8B
Stockholders' Equity
CLB
CLB
EPR
EPR
Q1 26
$275.1M
Q4 25
$266.0M
$2.3B
Q3 25
$271.3M
$2.3B
Q2 25
$261.3M
$2.3B
Q1 25
$253.4M
$2.3B
Q4 24
$246.6M
$2.3B
Q3 24
$250.7M
$2.4B
Q2 24
$240.3M
$2.4B
Total Assets
CLB
CLB
EPR
EPR
Q1 26
$587.7M
Q4 25
$584.0M
$5.7B
Q3 25
$591.4M
$5.5B
Q2 25
$602.1M
$5.6B
Q1 25
$591.5M
$5.5B
Q4 24
$585.1M
$5.6B
Q3 24
$600.5M
$5.7B
Q2 24
$597.8M
$5.6B
Debt / Equity
CLB
CLB
EPR
EPR
Q1 26
Q4 25
0.41×
1.26×
Q3 25
0.42×
1.19×
Q2 25
0.48×
1.20×
Q1 25
0.49×
1.20×
Q4 24
0.51×
1.23×
Q3 24
0.56×
1.19×
Q2 24
0.61×
1.16×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
EPR
EPR
Operating Cash FlowLast quarter
$4.0M
$421.0M
Free Cash FlowOCF − Capex
$517.0K
$269.2M
FCF MarginFCF / Revenue
0.4%
147.1%
Capex IntensityCapex / Revenue
82.9%
Cash ConversionOCF / Net Profit
0.77×
6.29×
TTM Free Cash FlowTrailing 4 quarters
$22.5M
$568.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
EPR
EPR
Q1 26
$4.0M
Q4 25
$7.9M
$421.0M
Q3 25
$8.5M
$136.5M
Q2 25
$13.9M
$87.3M
Q1 25
$6.7M
$99.4M
Q4 24
$20.6M
$393.1M
Q3 24
$13.1M
$122.0M
Q2 24
$17.1M
$78.7M
Free Cash Flow
CLB
CLB
EPR
EPR
Q1 26
$517.0K
Q4 25
$5.0M
$269.2M
Q3 25
$6.5M
$132.1M
Q2 25
$10.4M
$82.4M
Q1 25
$3.9M
$84.7M
Q4 24
$17.4M
$129.2M
Q3 24
$10.4M
$121.5M
Q2 24
$14.3M
$71.3M
FCF Margin
CLB
CLB
EPR
EPR
Q1 26
0.4%
Q4 25
3.6%
147.1%
Q3 25
4.8%
72.5%
Q2 25
8.0%
46.3%
Q1 25
3.1%
48.4%
Q4 24
13.4%
72.9%
Q3 24
7.7%
67.3%
Q2 24
10.9%
41.2%
Capex Intensity
CLB
CLB
EPR
EPR
Q1 26
Q4 25
2.1%
82.9%
Q3 25
1.5%
2.4%
Q2 25
2.7%
2.7%
Q1 25
2.3%
8.4%
Q4 24
2.5%
148.9%
Q3 24
2.0%
0.3%
Q2 24
2.2%
4.2%
Cash Conversion
CLB
CLB
EPR
EPR
Q1 26
0.77×
Q4 25
1.61×
6.29×
Q3 25
0.60×
2.05×
Q2 25
1.31×
1.15×
Q1 25
1.51×
Q4 24
2.78×
Q3 24
1.12×
2.62×
Q2 24
1.90×
1.74×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLB
CLB

Segment breakdown not available.

EPR
EPR

Experiential Reportable Operating Segment$173.3M95%
Education Reportable Operating Segment$9.5M5%

Related Comparisons